Login / Signup

Circulating MicroRNAs in Gastrointestinal Cancer.

Masahisa OhtsukaKazuya IwamotoAtsushi NaitoMitsunobu ImasatoSatoshi HyugaYujiro NakaharaManabu MikamoriKenta FurukawaJeongho MoonTadafumi AsaokaKentaro KishiAwad ShammaHiroki AkamatsuTsunekazu MizushimaHirofumi Yamamoto
Published in: Cancers (2021)
Gastrointestinal cancer (GIC) is a common disease and is considered to be the leading cause of cancer-related death worldwide; thus, new diagnostic and therapeutic strategies for GIC are urgently required. Noncoding RNAs (ncRNAs) are functional RNAs that are transcribed from the genome but do not encode proteins. MicroRNAs (miRNAs) are short ncRNAs that are reported to function as both oncogenes and tumor suppressors. Moreover, several miRNA-based drugs are currently proceeding to clinical trials for various diseases, including cancer. In recent years, the stability of circulating miRNAs in blood has been demonstrated. This is of interest because these miRNAs could be potential noninvasive biomarkers of cancer. In this review, we focus on circulating miRNAs associated with GIC and discuss their potential as novel biomarkers.
Keyphrases
  • papillary thyroid
  • clinical trial
  • squamous cell
  • lymph node metastasis
  • randomized controlled trial
  • childhood cancer
  • young adults
  • risk assessment
  • drug induced